Evidence map›Paper›PMID 38861309›Full record

ArticleFuture oncology (London, England)2024

OCEANIA: real-world study of ovarian cancer treatment patterns across multiple lines of therapy in Argentina and Brazil.

Claudia Soares, Gabriela Abreu, Thiago Luiz Nogueira da Silva, Juliana Queiroz, Patricia Menezes, Graziela Bernardino, Tatiana Pires, Mariano Carrizo, Rosana Felice, Maria Cecilia Riggi and 3 more

Abstract read
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Claudia SoaresGSK, Rio de Janeiro, Brazil.ORCID 0000-0002-8425-2066
Gabriela AbreuGSK, Rio de Janeiro, Brazil.ORCID 0000-0003-4420-9116
Thiago Luiz Nogueira da SilvaGSK, Rio de Janeiro, Brazil.
Juliana QueirozGSK, Rio de Janeiro, Brazil.
Patricia MenezesGSK, Rio de Janeiro, Brazil.
Graziela BernardinoGSK, Rio de Janeiro, Brazil.
Tatiana PiresGSK, Rio de Janeiro, Brazil.
Mariano CarrizoGSK, Buenos Aires, Argentina.
Rosana FeliceGSK, Buenos Aires, Argentina.
Maria Cecilia RiggiHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Florencia CraveroHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
André Luiz Alves Ribeiro de SouzaOrizon, Barueri City, São Paulo, Brazil.
Laura JotimlianskyGSK, Buenos Aires, Argentina.

Funding

GlaxoSmithKline 213815
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ovarian NeoplasmsAdultAgedAntineoplastic Combined Chemotherapy ProtocolsArgentinaBrazilFemaleHumansMiddle Agedantineoplastic agentsArgentinaBrazildrug therapyovarian cancer

Identifiers

PMID38861309
PMCPMC11526727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.